SCHOTT Pharma
Christian Arends is an experienced professional in business development within the pharmaceutical industry, currently serving as the Head of Business Development at SCHOTT Pharma since August 2022. Previously, Christian held the position of Senior Business Development Manager and Business Development Manager at SCHOTT, focusing on educating and consulting on pharmaceutical primary packaging and fill & finish processes, particularly with sterile ready-to-use vials for global Key Accounts. Christian's expertise also includes a role in new market development and marketing at Evonik, as well as experiences in market analysis and research. Academic credentials include a Master of Arts in Sales and Marketing from RheinMain University of Applied Sciences and a Bachelor of Arts in Industrial Management from DHBW Mannheim.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social